Genelux Corporation CEO Thomas Zindrick to Participate in Virtual Fireside Chat on Clinical Developments for Olvi-Vec
Genelux Corporation's CEO will discuss its lead candidate, Olvi-Vec, in a virtual session on December 16, 2024.Quiver AI SummaryGenelux Corporation, a late clinical-stage immuno-oncology firm, announced...
Young Adults and Pancreatic Cancer: What the 80% Rise in Diagnoses Means for Future Treatment
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GNLX),(NASDAQ:CRNX),(NYSE:PFE),(NASDAQ:SGEN) EQNX::TICKER_END
Navigating the Surge in Pancreatic Cancer: The Innovative Strategies Offering New Hope
USA News Group – Researchers are becoming increasingly concerned with the rates of cancer on the rise among people under 50. A recent study found a nearly 80% global increase in the number of under-50s...
Why Shares of Genelux Climbed This Week
The company's shares rose on signs it might be getting closer to its first biologics license application.
Why Shares of Genelux Corporation Jumped This Week
The company reported positive phase 2 trial news regarding its lead therapy.